Concepedia

Christopher J. O’Callaghan

CJ

85

Publications

12.4K

Citations

42

H-Index

1989

Active since

Affiliations

Queen's University(Current)

Princess Margaret Cancer Centre

Peter MacCallum Cancer Centre

University of Warwick

Université de Montréal

Christopher J. O’Callaghan is an author at Queen's University specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1989–2025

85

Publications

85

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James Perry, Normand Laperrière, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller et al. · Journal of Clinical Oncology · 2005 · 702 citations · Full text

Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer

Mark D. Pegram, G. Konecny, Christopher J. O’Callaghan et al. · JNCI Journal of the National Cancer Institute · 2004 · 509 citations

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

Juanita Crook, Christopher J. O’Callaghan, Graeme Duncan et al. · New England Journal of Medicine · 2012 · 489 citations · Full text

Rows per page

1–5 of 85